Factors associated with hospital admission in hereditary angioedema attacks: A multicenter prospective study

Annals of Allergy, Asthma and Immunology

Volumn 114, Issue 6, 2015, Pages 499-503

  Javaud, Nicolas ^a   Gompel, Anne ^d   Bouillet, Laurence ^f   Boccon Gibod, Isabelle ^f   Cantin, Delphine ^e   Smaiti, Nadia ^g   Carpentier, Françoise ^f   Boubaya, Marouane ^c   Launay, David ^g   Adnet, Frédéric ^a   Fain, Olivier ^b  

^a UNIVERSITÉ PARIS 13   (France)

^b HÔPITAL JEAN VERDIER   (France)

^c AVICENNE HOSPITAL   (France)

^d HÔTEL DIEU   (France)

^e ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^f GRENOBLE UNIVERSITY HOSPITAL   (France)

^g UNIV LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; BRADYKININ; COMPLEMENT COMPONENT C1S INHIBITOR; ICATIBANT; TRANEXAMIC ACID; BRADYKININ B2 RECEPTOR ANTAGONIST; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ANGIONEUROTIC EDEMA; ARTICLE; CLINICAL ARTICLE; EMERGENCY WARD; FACE DISORDER; FEMALE; FRANCE; HOME CARE; HOSPITAL ADMISSION; HUMAN; LARYNX DISORDER; MALE; MULTICENTER STUDY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SELF INJECTION; ANALOGS AND DERIVATIVES; ANGIOEDEMAS, HEREDITARY; CLINICAL TRIAL; EMERGENCY HEALTH SERVICE; GENETICS; PATHOLOGY; STATISTICS AND NUMERICAL DATA;

ADULT; ANGIOEDEMAS, HEREDITARY; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BRADYKININ; BRADYKININ B2 RECEPTOR ANTAGONISTS; COMPLEMENT C1 INHIBITOR PROTEIN; EMERGENCY SERVICE, HOSPITAL; FEMALE; FRANCE; HUMANS; MALE; PATIENT ADMISSION; PROSPECTIVE STUDIES;

EID: 84930040054     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2015.04.005     Document Type: Article

References (20)

1. H. Longhurst, and M. Cicardi Hereditary angio-oedema Lancet 379 2012 474 481
2. M. Cicardi, W. Aberer, and A. Banerji Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group Allergy 69 2014 602 616
3. B.L. Zuraw, J.A. Bernstein, and D.M. Lang A focused parameter update: hereditary angioedema, acquired C1 inhibitor deficiency, and angiotensin-converting enzyme inhibitor-associated angioedema J Allergy Clin Immunol 131 2013 1491 1493
4. H.J. Longhurst, H. Farkas, and T. Craig HAE international home therapy consensus document Allergy Asthma Clin Immunol 6 2010 22
5. M. Cicardi, K. Bork, and T. Caballero Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an international working group Allergy 67 2012 147 157
6. D.A. Wilson, K. Bork, E.P. Shea, A.M. Rentz, M.B. Blaustein, and W.E. Pullman Economic costs associated with acute attacks and long-term management of hereditary angioedema Ann Allergy Asthma Immunol 104 2010 314 320.e2
7. L. Bouillet, D. Launay, and O. Fain Hereditary angioedema with C1 inhibitor deficiency: clinical presentation and quality of life of 193 French patients Ann Allergy Asthma Immunol 111 2013 290 294
8. T. Bowen, M. Cicardi, and H. Farkas 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema Allergy Asthma Clin Immunol 6 2010 24
9. J.P. Vandenbroucke, E. von Elm, and D.G. Altman Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration PLoS Med 4 2007 e297
10. K. Bork, J. Hardt, and G. Witzke Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency J Allergy Clin Immunol 130 2012 692 697
11. N. Javaud, A. Karami, and J. Stirnemann Bradykinin-mediated angioedema: factors prompting ED visits Am J Emerg Med 31 2013 124 129
12. N. Javaud, B. Floccard, and F. Gontier Bradykinin-mediated angioedema: factors associated with admission to an intensive care unit, a multicenter study [published online ahead of print] Eur J Emerg Med 31 2015 124 129
13. K. Bork, G. Meng, P. Staubach, and J. Hardt Hereditary angioedema: new findings concerning symptoms, affected organs, and course Am J Med 119 2006 267 274
14. T.J. Craig, A.K. Bewtra, and S.L. Bahna C1 esterase inhibitor concentrate in 1085 hereditary angioedema attacks - final results of the I.M.P.A.C.T.2 study Allergy 66 2011 1604 1611
15. K. Bork, G. Meng, P. Staubach, and J. Hardt Hereditary angioedema: new findings concerning symptoms, affected organs, and course Am J Med 119 2006 267 274
16. W. Aberer, M. Maurer, and A. Reshef Open-label, multicenter study of self-administered icatibant for attacks of hereditary angioedema Allergy 69 2014 305 314
17. H.B. Boysen, L. Bouillet, and E. Aygören-Pürsün Challenges of C1-inhibitor concentrate self-administration Int Arch Allergy Immunol 161 Suppl 1 2013 21 25
18. M. Levi, G. Choi, C. Picavet, and C.E. Hack Self-administration of C1-inhibitor concentrate in patients with hereditary or acquired angioedema caused by C1-inhibitor deficiency J Allergy Clin Immunol 117 2006 904 908
19. T.J. Craig, M.A. Rojavin, T. Machnig, H.-O. Keinecke, and J.A. Bernstein Effect of time to treatment on response to C1 esterase inhibitor concentrate for hereditary angioedema attacks Ann Allergy Asthma Immunol 111 2013 211 215
20. M. Maurer, W. Aberer, and L. Bouillet Hereditary angioedema attacks resolve faster and are shorter after early icatibant treatment PLoS One 8 2013 e53773